**This is applicable during office hours to Sole holder Resident Indian accounts which are KRA verified, also account would be open after all procedures relating to IPV and client due diligence are completed. *Account opening charges are NIL. There is no AMC charged on Demat account for the first year. All other charges will apply as per agreed tariff rates.

• Trades executed under this facility are subject to brokerage rate of 0.5% of transaction value plus statutory charges such as stamp duty, STT, Exchange Transaction charges and such other levies. This rate shall override any agreed tariff as per KYC executed by you or otherwise.
• This product is 100% marginable in advance of execution of trade. Please ensure that you have necessary balances in your ledger account prior to placing orders for purchase of securities.
• Once you place an order for purchase, please note that allocation will be done as equal amount and no weights will be assigned to any stock across the listed basket of securities.
• The basket of securities that are purchased would depend upon your point of subscription to this product. The list of securities in the basket may change over a period of time for different clients based on research recommendations.
• Stocks purchased under this facility cannot be pledged and therefore, they cannot be used as collateral for any financing arrangements, for Margin Trading facility or as margin for your other trading activities, if any.
• This facility involves purchases and sales in securities in Equities Segment only and does not cover any kind of derivatives or other securities. Please log in to your trading account on Sharekhan website or visit the Sharekhan website or reach out to your RM for full and detailed research reports supporting the research recommendations herein.
• Understand that investment in securities are subject to market risk. Please read the relevant documents and seek independent tax / professional advise before consulting. Sharekhan does not in any way assure or guarantee returns through the securities listed in the basket. The securities listed therein may or may not be appropriate to your individual risk appetite.
• Shifting of the investment from one portfolio to another is not possible on the same day. Credit amount from the selling of a portfolio would be available to buy another portfolio on the next working day. However, rebalancing within a particular portfolio can be done on the same day.
• I agree to have read these terms including disclaimers prior to taking an investment decision or opting for this platform.

The offer is open only for a limited period at the sole discretion of Sharekhan Ltd. and applicable only to Sharekhan customers who register (using their Sharekhan Login ID and Password) and accept the InvesTiger Terms & Conditions and Disclaimers on the InvesTiger app on or before June 30, 2024. The offer is only for ₹ 0 Annual Fee. All other charges as well as taxes and other statutory/Exchange charges continue to apply. Past results and representations are not indicative of future performance and/or results.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. For detailed mutual fund disclaimer and registration office details, visit www.sharekhan.com.

RESEARCH - DISCLAIMER

Research Reports/Recommendations

The information/document contained herein has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This information/document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This information/document is subject to changes without prior notice. Kindly note that this information/document is based on technical analysis by studying charts of a stock's price movement and trading volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals (Technical specific). This information/document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this information/report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this information/report.

The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors, and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This information/document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this information/report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this information/document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to herein (including the merits and risks involved) and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other recommendations/reports that are inconsistent with and reach different conclusion from the information presented in this recommendation/report.

This information/recommendation/report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country, or other jurisdiction, where such distribution, publication, availability, or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this information/document may come are required to inform themselves of and to observe such restriction. The analyst and/or associates (if any) certifies that the analyst and/or associates (if any) have not dealt or traded directly or indirectly in securities of the company and that all the views expressed in this document accurately reflect his/her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. The analyst and SHAREKHAN further certifies that neither he nor his relatives nor Sharekhan associates have any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of the company at the end of the month immediately preceding the date of publication of the research report nor have any material conflict of interest nor has served as officer, director or employee or engaged in market making activity of the company. Further, the analyst and SHAREKHAN has also not been a part of the team which has managed or co-managed the public offerings of the company in the past twelve months, and no part of the analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document. Sharekhan Ltd or its associates or analysts have not received any compensation for investment banking, merchant banking, brokerage services or any compensation or other benefits from the subject company or from third party in the past twelve months in connection with the research report.

InvesTiger is a product pre-approved by NSE only in the NSE segment.

Either, SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal, or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.

The securities quoted are exemplary and not recommendatory or actual. Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com

Compliance Officer: Ms. Binkle R. Oza; Tel: 022-62263303; Email ID: complianceofficer@sharekhan.com

SEBI Registration details: Registered Office Address: Sharekhan Limited, The Ruby, 18th Floor, 29 Senapati Bapat Marg, Dadar (West), Mumbai 400 028, Maharashtra, India. Tel: 022-67502000.
Correspondence Address: 10th Floor, Gigaplex Bldg. No. 9, Raheja Mindspace, Airoli Knowledge Park Rd, MSEB Staff Colony, TTC Industrial Area, Airoli, Navi Mumbai, Maharashtra 400708, India. Tel: 022 - 61169000/ 61150000; Fax no. 61169699

Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI (CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-DP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669; Research Analyst: INH000006183. For any complaints, email us at igc@sharekhan.com

^Sharekhan has been recognized as one of the 'Most Trusted Brands of India 2023' at a gala event on 24th March 2023 by Marksmen Daily after an in-depth study and research by Leadcap Ventures.